Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Infect Dis Clin North Am ; 15(3): 953-81, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11570148

ABSTRACT

The chronic renal failure patient with diabetes has a lower limb amputation rate 10 times greater than the diabetic population at large. In studies of causal pathways leading to non-traumatic related lower extremity amputation, foot ulcers preceded approximately 84% of the amputations. Even though foot ulcers are more likely to develop in patients with diabetic nephropathy, they are no less likely to heal than are those in diabetic patients with normal renal function. Consequently, attempts to save the diabetic foot even in this high-risk population are justified. The pathogenesis of foot ulceration in the chronic renal failure patient with diabetes is primarily due to peripheral neuropathy. Loss of protective sensation due to sensory neuropathy combined with motor and autonomic neuropathy and macrovascular compromise result in increased risk for foot complications. Evaluation of the foot includes a selective history and a focused examination of skin integrity, presence of sensory neuropathy or vascular insufficiency, and biomechanical and footwear inspection. Effective treatment of diabetic foot complications include appropriate antibiotics (when indicated), meticulous wound care, off-loading, vascular surgery (when indicated), and selective/elective or prophylactic nonvascular surgery. Failure to heal an ulcer can often be traced to common pitfalls, which include: A "cavalier" attitude. W.N.L. exam (We Never Looked). Inadequate off-loading. Failure to establish depth of ulcer and miss "probe to bone." Non-healing means unrelieved pressure and/or no blood. Failure to correct edema. The multidisciplinary diabetic foot clinic model provides an ideal setting for early intervention, treatment, and assistance with preventive strategies.


Subject(s)
Diabetic Foot/complications , Diabetic Nephropathies/complications , Kidney Failure, Chronic/complications , Amputation, Surgical , Anti-Bacterial Agents/therapeutic use , Diabetic Foot/prevention & control , Diabetic Foot/therapy , Diabetic Nephropathies/therapy , Diabetic Neuropathies/prevention & control , Humans
2.
J Rehabil Res Dev ; 38(3): 309-17, 2001.
Article in English | MEDLINE | ID: mdl-11440262

ABSTRACT

OBJECTIVE: To compare patients with diabetes and new onset foot ulcers treated in Veterans Health Administration (VHA) and non-VHA settings. METHODS: The treatment of patients with new onset diabetic foot ulcers was prospectively monitored in three VHA and three non-VHA hospitals and outpatient settings until ulcer healing, amputation, or death. RESULTS: Of the 302 individuals enrolled in this study, 47% were veterans receiving VHA care. There were no significant differences between veterans and nonveterans in baseline wound classification, diabetes severity, or comorbid conditions. Veterans received significantly fewer sharp debridements, total contact casts, and custom inserts than their nonveteran counterparts, and they had significantly more x-rays, local saline irrigations, IV antibiotics, and prescriptions for bed rest. The percentage of amputations was higher in veterans but did not achieve statistical significance. CONCLUSIONS: Many commonly held stereotypes of veteran men were not found. Veterans and nonveterans with foot ulcers were similar in terms of health and foot history, diabetes severity, and comorbid conditions. There was considerable variation in treatment of diabetic foot ulcers between VHA and non-VHA care. Yet this variation did not result in statistically significant differences in ulcer outcomes.


Subject(s)
Diabetic Foot/therapy , Hospitals, Veterans/statistics & numerical data , Practice Patterns, Physicians'/statistics & numerical data , Aged , Debridement , Female , Humans , Male , Middle Aged , Prospective Studies , United States , United States Department of Veterans Affairs
3.
J Am Geriatr Soc ; 46(7): 849-53, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9670871

ABSTRACT

OBJECTIVES: To assess colonization and serious infection with yeasts and the risk factors that are associated with colonization by these organisms. DESIGN: Monthly surveillance for colonization and infection over a period of 2 years. SETTING: A long-term-care facility (LTCF) attached to an acute-care Veterans Affairs Medical Center. PARTICIPANTS: The 543 men and 10 women in the facility. MEASUREMENTS: Colonization and serious infection rates with yeasts. Analysis of risk factors associated with yeast colonization of residents. RESULTS: Colonization rates were relatively stable during the 2-year period (53+/-1.8% patients colonized per month). Candida albicans was the most common colonizer, found in 35+/-.9% of patients colonized per month. The pharynx was the most commonly colonized site, with 41+/-1.4% of patients per month with pharyngeal colonization. Eighty-four percent of patients remaining in the facility for 3 or more months were colonized by yeast at some time during their stay. Presence of neurogenic bladder, leg amputation, or a low serum albumin were independently associated with yeast colonization; neither diabetes mellitus nor functional status was a risk factor for colonization by yeasts. Only four serious yeast infections in four patients (esophagitis and three urinary tract infections) were found during the 2-year period; all infections occurred in patients who were colonized by yeasts previously. CONCLUSION: In our LTCF, colonization of patients by yeasts occurred commonly in those residents remaining in the facility for 3 or more months. However, serious yeast infections occurred infrequently. It is likely that colonization of residents of LTCFs by yeasts may only become clinically important when the patient is transferred to an acute-care hospital where additional risk factors may allow the development of serious yeast infection.


Subject(s)
Candidiasis/epidemiology , Cross Infection/epidemiology , Aged , Candida/isolation & purification , Candidiasis/microbiology , Cross Infection/microbiology , Female , Hospital Bed Capacity, 300 to 499 , Hospitals, Veterans , Humans , Incidence , Long-Term Care , Male , Michigan/epidemiology , Middle Aged , Risk Factors
4.
Mycoses ; 38(1-2): 29-36, 1995.
Article in English | MEDLINE | ID: mdl-7637679

ABSTRACT

Instigated by an increase in serious human Candida infections and aided by advances in technology, there has been renewed interest in the study of the epidemiology of fungal infections. Among the newer techniques available, contour-clamped homogeneous electric field (CHEF) electrophoresis has shown great promise as a tool for typing strains of Candida albicans. However, few studies have addressed the reproducibility of the preparatory and electrophoretic methods. Through a series of analyses on clinical isolates of C. albicans, we were able to demonstrate that (a) sample preparation induced no appreciable artifacts in CHEF banding patterns; (b) the electrophoretic patterns were reproducible over time; (c) changes in colony morphology were not associated with changes in the electrophoretic pattern, and (d) the method was more sensitive than restriction enzyme analysis (REA) for demonstrating strain differences. CHEF electrophoresis is a sensitive and reproducible tool for the study of Candida epidemiology. Further use and study of this methodology is warranted.


Subject(s)
Candida albicans/classification , Mycological Typing Techniques , Electrophoresis , Prohibitins , Reproducibility of Results
5.
Antimicrob Agents Chemother ; 38(10): 2495-7, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7840596

ABSTRACT

For 212 oropharyngeal isolates of Candida albicans, the fluconazole MICs for 50 and 90% of strains tested were 0.5 and 16 micrograms/ml, respectively, and those of itraconazole were 0.05 and 0.2 micrograms/ml, respectively. Of 16 isolates for which fluconazole MICs were > 64 micrograms/ml, itraconazole MICs for 14 were < or = 0.8 micrograms/ml and for 2 were > 6.4 micrograms/ml. Most fluconazole-resistant strains remained susceptible to itraconazole; whether itraconazole will prove effective for refractory thrush remains to be shown.


Subject(s)
AIDS-Related Opportunistic Infections/microbiology , Candida albicans/drug effects , Fluconazole/pharmacology , Itraconazole/pharmacology , Oropharynx/microbiology , Drug Resistance, Microbial , Humans , Microbial Sensitivity Tests
6.
Am J Med ; 97(4): 339-46, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7942935

ABSTRACT

PURPOSE: To study the epidemiology of oral candidiasis and the effect of treatment of thrush in human immunodeficiency virus (HIV)-infected patients. PATIENTS AND METHODS: We conducted a prospective observational study of 92 patients over 1 year, including a nonblinded, randomized treatment trial of thrush with clotrimazole troches or oral fluconazole. Oral sites were cultured monthly and when thrush occurred. Candida albicans strains were typed by contour-clamped homogeneous electric field (CHEF) electrophoresis. Changes in strains were evaluated over time and in regard to their associations with particular sites, episodes of thrush, relapse after treatment, and colonization of sexual partners. Susceptibility to fluconazole was tested and CHEF analysis was done on these strains to determine the epidemiology of fluconazole resistance. RESULTS: Yeasts colonized 84% of patients. C albicans accounted for 81% of all isolates and was separated into 34 distinct strains. Most patients had persistent carriage of 1 or 2 dominant strains of C albicans. Three couples shared strains. Nineteen different C albicans strains caused 82 episodes of thrush in 45 patients. CD4 < 200/microL was associated with development of thrush. Clinical cure rates were similar with fluconazole (96%) and clotrimazole (91%), but mycologic cure was better with fluconazole (49%) than clotrimazole (27%). Following mycologic cure, colonization recurred with the same strain 74% of the time. Colonization with Torulopsis glabrata and Saccharomyces cerevisiae increased after treatment with either drug, but these organisms were never a sole cause of thrush. In a subset of 35 patients followed for over 3 months in whom fluconazole susceptibilities were performed, minimum inhibitory concentrations (MICs) to fluconazole increased only in those on fluconazole prophylaxis. Clinical failure of fluconazole was associated with an MIC > or = 64 micrograms/mL in 3 patients, and with an MIC of 8 micrograms/mL in 1 patient. In 2 of these 4 patients, the prior colonizing strain developed fluconazole resistance. In the other 2, new resistant strains were acquired. CONCLUSIONS: Many different strains of C albicans colonize and cause thrush in patients infected with HIV. Patients are usually persistently colonized with a single strain, and recurrences following treatment are usually due to the same strain. Transmission of strains may occur between couples. Fluconazole and clotrimazole are equally effective in treating thrush, but mycologic cure occurs more often with fluconazole. Fluconazole resistance in C albicans occurs most often in patients who have low CD4 counts and are taking fluconazole prophylactically for recurrent thrush. Fluconazole resistance may occur through acquisition of a new resistant strain or by development of resistance in a previously susceptible strain.


Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , Candidiasis/drug therapy , Clotrimazole/therapeutic use , Fluconazole/therapeutic use , HIV Infections/complications , Mouth/microbiology , AIDS-Related Opportunistic Infections/microbiology , Adult , Candida/drug effects , Candida/isolation & purification , Candidiasis/microbiology , Drug Resistance, Microbial , Electrophoresis/methods , Humans , Karyotyping , Male , Prospective Studies , Risk Factors , Treatment Outcome
7.
Clin Infect Dis ; 19(1): 60-6, 1994 Jul.
Article in English | MEDLINE | ID: mdl-7948559

ABSTRACT

Chronic meningitis is an uncommon manifestation of candidiasis. We present the case of an elderly woman who had symptoms such as headache, malaise, and fever for 8 months and was found to have Candida albicans meningitis, and we review 17 similar cases. An underlying illness or risk factor for candidiasis was present in only 13 (72%) of the 18 patients. Headache, fever, and nuchal rigidity were the predominant clinical findings. Analysis of CSF showed either mononuclear or neutrophilic pleocytosis, an elevated protein level, and a decreased level of glucose. Only 17% of CSF smears were positive, and only 44% of initial CSF cultures yielded Candida species. In four cases, Candida species grew only after special techniques were used; in three cases, CSF cultures remained negative. The overall mortality associated with candidal meningitis was 53%, but among 12 patients who were treated and followed, the rate was 33%. In addition to acute meningitis seen with disseminated infection, Candida species can cause chronic meningitis that mimics tuberculosis and the more common fungal meningitides, such as cryptococcosis.


Subject(s)
Candidiasis/diagnosis , Meningitis, Fungal/diagnosis , Aged , Amphotericin B/therapeutic use , Candida albicans/isolation & purification , Candidiasis/cerebrospinal fluid , Candidiasis/drug therapy , Cerebrospinal Fluid Proteins/analysis , Female , Flucytosine/therapeutic use , Glucose/cerebrospinal fluid , Humans , Leukocyte Count , Meningitis, Fungal/cerebrospinal fluid , Meningitis, Fungal/drug therapy , Neutrophils
8.
Arch Intern Med ; 153(19): 2268-74, 1993 Oct 11.
Article in English | MEDLINE | ID: mdl-8215730

ABSTRACT

Rubella immunization or infection is an uncommonly recognized cause of acute, recurrent, or persistent musculoskeletal manifestations. After routine rubella immunization, two women presented with the onset of polyarthralgia, arthritis, maculopapular rash, fever, paresthesia, and malaise with persistent or recurrent manifestations lasting longer than 24 months after vaccination. The patients expressed rubella virus RNA in peripheral-blood leukocytes 10 and 8 months after vaccination, respectively, in contrast to repeated negative results in asymptomatic rubella-immunized controls. One patient developed significantly depressed antibody responses to rubella virus after vaccination and experienced a prolonged clinical improvement after a 3-month course of intravenous immune globulin. The second patient had normal antibody responses to rubella virus and underwent no clinical improvement during or after intravenous immune globulin therapy. Rubella immunization or infection should be considered as additional causative factors in evaluation of acute and continuing musculoskeletal syndromes.


Subject(s)
Arthritis, Infectious/etiology , Rubella Vaccine/adverse effects , Adult , Arthritis, Infectious/therapy , Base Sequence , Chronic Disease , Female , Humans , Immunoglobulins, Intravenous/therapeutic use , Molecular Sequence Data , Rubella/etiology , Rubella virus/isolation & purification
9.
Clin Orthop Relat Res ; (287): 233-6, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8448949

ABSTRACT

Pyarthrosis of the knee with Nocardia asteroides occurred concomitantly with thorn synovitis in an 11-year-old boy who was otherwise healthy. A review of the orthopedic and infectious disease literatures did not disclose a similar report. Contrary to common teaching, effusions from joints violated by thorns should not be presumed sterile. Culture for bacterial and fungal infections is recommended when treating cases of thorn synovitis.


Subject(s)
Arthritis, Infectious/complications , Knee Joint/microbiology , Nocardia Infections/complications , Nocardia asteroides , Synovitis/complications , Child , Humans , Male , Synovitis/microbiology , Trees
SELECTION OF CITATIONS
SEARCH DETAIL
...